Compound Detail

CHEMBL4167834

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C[C@H]1CCC/C=C/[C@@H]2C[C@H](O)C[C@H]2[C@H](OC(=O)CCCC(=O)OCCCOc2no[n+]([O-])c2S(=O)(=O)c2ccccc2)/C=C/C(=O)O1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4167834
Phase	Preclinical
Structure Type	MOL
InChI Key	GLYAEIRGOJGXPF-BFDAGPSHSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

676.7

MW (Da)

3.15

ALogP

HBA

HBD

195.5

PSA (Å²)

0.11

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 7.02

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
PC-3 CHEMBL390	IC50	7.02	7.02	95.0	1
HepG2 CHEMBL395	IC50	5.75	5.75	1800.0	1
HT-29 CHEMBL384	IC50	5.24	5.24	5700.0	1
L02 CHEMBL4296457	IC50	5.17	5.17	6700.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
PC-3	IC50	=	95.0	nM	7.02	Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay	28494251
HepG2	IC50	=	1800.0	nM	5.75	Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay	28494251
HT-29	IC50	=	5700.0	nM	5.24	Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay	28494251
L02	IC50	=	6700.0	nM	5.17	Cytotoxicity against human L02 cells assessed as reduction in cell viability aft...	28494251

PubMed	DOI	Target Context	# Activities
28494251	10.1016/j.ejmech.2017.05.018	PC-3	1
28494251	10.1016/j.ejmech.2017.05.018	HT-29	1
28494251	10.1016/j.ejmech.2017.05.018	HepG2	1
28494251	10.1016/j.ejmech.2017.05.018	L02	1
28494251	10.1016/j.ejmech.2017.05.018	Unchecked	1

Data from ChEMBL 36 via Core Engine